Fourlis S A : Document providing information under Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (Article 1 par. 5.h)

FOURLIS HOLDINGS S.A.

Document providing information under Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (Article 1 par. 5.h) regarding the trading of Fourlis Holdings shares following the exercise of Stock Option Rights.

FOURLIS HOLDINGS S.A. informs the investment community that according to the terms of the Stock Option Plan Programs that have been approved by the Extraordinary General Meeting of the Shareholders of the company dated 27.09.2013 (hereafter "Program B'") and by the Ordinary Meeting of the Shareholders of the Company dated 16.06.2017 (hereafter "Program C'"), the executives of the Company and its affiliated companies, who are referred within the relevant Board of Directors resolutions dated 25.11.2013, 24.11.2014, 23.11.2015, 20.11.2017, 19.11.2018, 18.11.2019, 23.11.2020 and 22.11.2021, were invited to submit their intention to exercise until 30.11.2021, the stock option rights corresponding to 1.850.565 in total new ordinary shares of the Company.

More specifically:

		Program B (2013)			Program C (2017)
	1st Series	2nd Series	3rd Series	1st Series	2nd Series	3rd Series	4th Series
Number of stock option rights to be exercised	0	0	83.574	625.558	499.863	384.952	256.618
Exercise Price		3,2226 €			5,5637 €
Declaration Period for the intention to exercise			22/11/2021 - 30/11/2021
Payment Period of the total exercise amount			1/12/2021 - 15/12/2021

Following the announcement dated 15.12.2021, the Company hereby informs the investment community regarding the implementation of the Stock Option Plans for 2021, as follows:

1. From 22.11.2021 until 30.11.2021, eight (8) executives of FOURLIS Group have declared in writing their intention to exercise their stock option rights from "Program B" and they deposit on time up until 15.12.2021, the respective amount to the designated bank account of the Company.
2. 39.943 new common Company shares, of a nominal value € 1,00 each, were allotted in total.
3. The exercise price of the new shares was € 3,2226 per share.
4. The total purchase price for the allotted shares € 128.720,33 was credited in full in the special account.
5. On January 11, 2022 the General Commercial Registry (G.E.MI.) by virtue of announcement 2773271 approved and registered the increase of the share capital by €39.943,00, corresponding to the nominal value of the new 39.943 shares of nominal value €1,00 each and exercise price of €3,2226. Following the above share capital increase, the share capital of the Company amounts to €
   52.131.944,00 and is divided into 52.131.944 shares, with a nominal value of € 1,00 each.
6. The Company will take all necessary actions, according to the legislation in force, for the introduction of the new shares for trading in the Athens Exchange.

Responsible for compiling this informative material, and ensuring the accuracy of the information presented therein, are:

1. Mrs Anastasia Spirou, Group HR Director, 18-20 Sorou street, Maroussi, tel.: [phone]
2. Mr George Alevizos, Investor Relations Manager, 18-20 Sorou street, Maroussi, tel.: [phone]

The Information Note is available at Company's office, 18-20 Sorou street, Maroussi, 151 25 Athens, Greece, and in electronic form from our website (www.fourlis.gr).

For additional information, please contact Mrs V. Loukaki at the Investors Relations Department, tel.: [phone], during working hours.

Maroussi, January, 12 2022

Fourlis Holdings S.A.

I.R. Department